Simonsen S
Eur J Cardiol. 1978 Aug;8(1):9-18.
The effect of verapamil (Isoptin) on coronary hemodynamics was studied in 18 patients with coronary heart disease. The continuous infusion thermodilution technique was used to measure cardiac venous blood flow. At rest, verapamil produced a 13% decrease in coronary arteriolar resistance, a 5% decrease in coronary arteriovenous oxygen difference and a 19% increase in left ventricular efficiency index. No significant effect was noted on myocardial blood flow, oxygen consumption or oxygen consumption per unit of left ventricular pressure work. No change occurred in any of the measured parameters during a submaximal stress test after drug administration. The findings are discussed in relation to the general hemodynamic effects of the drug. It is concluded that verapamil is a mild coronary vasodilator and that myocardial oxygen consumption, in relation to performed left ventricular work, is unaltered by the drug up to a near-maximal work-load.
对18例冠心病患者研究了维拉帕米(异搏定)对冠状动脉血流动力学的影响。采用连续输注热稀释技术测量心脏静脉血流量。静息时,维拉帕米使冠状动脉小动脉阻力降低13%,冠状动脉动静脉氧差降低5%,左心室效率指数提高19%。对心肌血流量、氧耗量或每单位左心室压力功的氧耗量无显著影响。给药后次极量应激试验期间,所测参数均无变化。结合该药物的一般血流动力学效应讨论了这些发现。得出的结论是,维拉帕米是一种轻度冠状动脉血管扩张剂,在接近最大工作量时,该药物不会改变与左心室做功相关的心肌氧耗量。